down arrow

Sun Pharma.Inds.

44
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,692.15
40.15 (2.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sun Pharma.Inds. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
11,087.00
9,408.00
4,481.00
2,799.00
5,009.00
3,810.00
Adjustment
1,554.00
2,722.00
1,974.00
1,809.00
1,992.00
1,968.00
Changes In working Capital
1,062.00
-5,661.00
1,559.00
2,564.00
898.00
-2,696.00
Cash Flow after changes in Working Capital
13,704.00
6,469.00
8,015.00
7,173.00
7,900.00
3,082.00
Cash Flow from Operating Activities
12,134.00
4,959.00
8,984.00
6,170.00
6,554.00
2,196.00
Cash Flow from Investing Activities
-762.00
-7,219.00
-5,555.00
406.00
-2,225.00
-310.00
Cash Flow from Financing Activities
-6,710.00
2,376.00
-5,193.00
-5,980.00
-5,715.00
-2,730.00
Net Cash Inflow / Outflow
4,661.00
115.00
-1,764.00
596.00
-1,385.00
-844.00
Opening Cash & Cash Equivalents
4,623.00
4,508.00
6,273.00
5,676.00
7,062.00
7,906.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
9,285.00
4,623.00
4,508.00
6,273.00
5,676.00
7,062.00
Compare Cash Flow Results of Sun Pharma.Inds.
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
11087.89
2163
8,924.00
412.62%
Adjustment
1554.4
81
1,473.00
1819.01%
Changes In working Capital
1062.13
-607
1,669.00
274.98%
Cash Flow after changes in Working Capital
13704.42
1637
12,067.00
737.17%
Cash Flow from Operating Activities
12134.98
1261
10,873.00
862.33%
Cash Flow from Investing Activities
-762.9
-269
-493.00
-183.61%
Cash Flow from Financing Activities
-6710.16
-799
-5,911.00
-739.82%
Net Cash Inflow / Outflow
4661.92
193
4,468.00
2315.50%
Opening Cash & Cash Equivalents
4623.73
170
4,453.00
2619.84%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
9285.65
363
8,922.00
2458.03%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 144.69% vs -44.80% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
12,134.98
4,959.33
144.69%